High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis.
about
Oral ulceration and bleeding associated with pancreatic enzyme supplementation in a German shepherd with pancreatic acinar atrophyPathophysiology of cystic fibrosis and drugs used in associated digestive tract diseasesEmergency laparoscopic ileo-colic resection and primary intracorporeal anastomosis for Crohn's acute ileitis with free perforation and faecal peritonitis: first ever reported laparoscopic treatmentFacing Terminal Ileitis: Going Beyond Crohn's DiseaseCalprotectin in cystic fibrosis.Enzyme replacement therapy for pancreatic insufficiency: present and futureStudy design considerations for evaluating the efficacy and safety of pancreatic enzyme replacement therapy in patients with cystic fibrosis.Diagnosis and treatment of pancreatic exocrine insufficiency.Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian Association for the Study of the PancreasDiagnosing malabsorption with systemic lipid profiling: pharmacokinetics of pentadecanoic acid and triheptadecanoic acid following oral administration in healthy subjects and subjects with cystic fibrosis.Is fibrosing colonopathy an immune mediated disease?Maintenance of growth in cystic fibrosis despite reduction in pancreatic enzyme supplementation.Nutrition for patients with cystic fibrosis.Systematic review: pancreatic enzyme treatment of malabsorption associated with chronic pancreatitisPancreatic enzyme pharmacotherapy.Delayed release pancrelipase for the treatment of pancreatic exocrine insufficiency associated with cystic fibrosis.Progress in cystic fibrosis and the CF Therapeutics Development NetworkCystic fibrosis-related dyslipidemia.Nutritional considerations in patients with cystic fibrosis.Pancreatic enzyme-replacement therapy in CF: considerations for the USA.Pancreatic enzyme products: digesting the changes.Malnutrition in cystic fibrosis: a review.An overview of the diagnosis and management of nutrition in chronic pancreatitis.The pharmacologic treatment of short bowel syndrome: new tricks and novel agents.Beyond pancreatic insufficiency and liver disease in cystic fibrosis.Gastric lipase secretion in children with gastritisSuccessful non-invasive treatment of stricturing fibrosing colonopathy in an adult patient.Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis.Practical guide to exocrine pancreatic insufficiency - Breaking the myths.In Vitro Comparison of Physical Parameters, Enzyme Activity, Acid Resistance, and pH Dissolution Characteristics of Enteric-Coated Pancreatic Enzyme Preparations: Implications for Clinical Variability and Pharmacy Substitution.Less common etiologies of exocrine pancreatic insufficiency.Pancreatic Enzyme Replacement Therapy use in infants with Cystic Fibrosis Diagnosed by Newborn Screening.Diagnosis and management of pancreatic exocrine insufficiency (PEI) in primary care: consensus guidance of a Canadian expert panel.Gastric function in children with cystic fibrosis: effect of diet on gastric lipase levels and fat digestion.Update on intestinal strictures.Challenges in the management of pancreatic exocrine insufficiency
P2860
Q24548155-0E9AD42F-B25F-4CBC-BE58-7A6907F1FDE2Q26825799-50B184A2-9F4B-412B-9405-29A549644443Q27319263-72880953-316F-41FF-8769-B9BC080CACB4Q28077774-C53DCFD6-029F-4748-99DA-A97099145023Q33722951-4C54BF54-9BE0-4C6A-AB66-8A0DD9418E6EQ34027667-3490465D-2907-4E20-9FBA-616A6F1C83DFQ34040502-453306BD-7AAF-4773-9DD9-837BBF5A8524Q34386682-ECC9AF0F-DC8E-4329-A2FD-F197D90D68E9Q34658130-7631183F-51EB-4144-8437-A67596B0C1C8Q35148967-749D3AE2-93D4-4E86-A8B8-88978BD7933DQ35255967-89982661-EFEB-48AA-92D6-FD2CA9D93402Q35259009-1830C59D-2526-4AB9-A9EB-5690C1B21443Q36281784-D58088EC-EC8A-4C47-9BDD-EC5A16F0A9DAQ36292225-482C44D0-8939-4886-ABA9-6F7785804C0BQ36837184-6C1E204C-F3B4-4856-AC35-BB8663179C48Q37052832-E8510E60-945B-4D8C-826B-71C2540B0F52Q37209004-A746E695-1F6C-4DAE-85BE-BA06206EE9F5Q37325530-E86DBBF1-2FF2-4628-9C77-D4CF161592B6Q37729993-568CFBBC-078E-4015-B86A-1A8485B95F4DQ37754982-3EB884E6-4318-4DA9-90AD-F32B71596EC9Q37871722-FF781835-B66D-4B07-924C-2C3D1FAC67A2Q38156392-ED66E89E-19E1-4F7D-A88B-2DDE4700F560Q38205327-DA52C65B-BE27-4676-88AB-B2CF3D96ADB1Q38232874-95CFBEA6-C9EC-442B-AEEA-7E51AFBA0A3DQ38800967-911BC7AF-E42F-43DB-951A-294270B67248Q41812960-65F7C338-FCC3-4BC3-9998-FAFED9D6BD9EQ41817145-CA2AE01E-6EAF-4B0B-AC17-7F093885240EQ42022559-DEDE7BE4-514E-43E1-B62A-0705862EA08CQ42322542-E75BFF9C-FC2B-4D5B-A298-96B6E2A21AABQ42535011-64CBE581-0604-4741-AE37-63AA381E9CE4Q45914147-619478A2-17DA-4A03-9BD6-21BDD3EE39EBQ47412357-215739C9-999E-4FCC-BD93-93FD5A8E34AAQ49554058-5CB0AAC8-A09F-4771-B6DE-4B43653937FAQ51532608-6D6C1ED9-4192-4A06-9203-A2BCE1D6D98BQ52865173-3AE9618B-8DDF-42FF-B15E-0D125D75AA4FQ58564354-689075E7-0C30-40E0-B5E7-11C36A150EF9
P2860
High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis.
description
1997 nî lūn-bûn
@nan
1997 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
High-dose pancreatic-enzyme su ...... children with cystic fibrosis.
@ast
High-dose pancreatic-enzyme su ...... children with cystic fibrosis.
@en
High-dose pancreatic-enzyme su ...... children with cystic fibrosis.
@nl
type
label
High-dose pancreatic-enzyme su ...... children with cystic fibrosis.
@ast
High-dose pancreatic-enzyme su ...... children with cystic fibrosis.
@en
High-dose pancreatic-enzyme su ...... children with cystic fibrosis.
@nl
prefLabel
High-dose pancreatic-enzyme su ...... children with cystic fibrosis.
@ast
High-dose pancreatic-enzyme su ...... children with cystic fibrosis.
@en
High-dose pancreatic-enzyme su ...... children with cystic fibrosis.
@nl
P2093
P1476
High-dose pancreatic-enzyme su ...... children with cystic fibrosis.
@en
P2093
Borowitz D
Burkhart GA
FitzSimmons SC
Hammerstrom T
Lloyd-Still JD
Lowenfels AB
P304
P356
10.1056/NEJM199705013361803
P407
P577
1997-05-01T00:00:00Z